MedTrace Logo

Physiologic Phacofluidics: Ghost Protocol

NCT06904404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2025-08-12

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to investigate the early post-operative benefits of performing phacoemulsification at physiologic intraocular pressures. The main questions it aims to answer are:

* Is there less post operative corneal edema?
* Is there less post operative inflammation?
* Is the post operative vision better? Participants will undergo phacoemulsification cataract surgery with either high or low IOP settings Researchers will compare post op corneal edema, inflammatory marker levels and vision

Conditions

  • Cataract

Interventions

PROCEDURE

Cataract surgery at high IOP

Cataract surgery at high IOP (conventional)

PROCEDURE

Cataract surgery at low IOP

Cataract surgery at low IOP

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Wolfe Eye Clinic

    lead OTHER

Principal Investigators

  • Edward H Hu, MD PhD · Wolfe Eye Clinic

Eligibility

Min Age
55 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-09-30
Completion
2024-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06904404 on ClinicalTrials.gov